Rafailovska, E.; Xhemaili, E.; Naumovska, Z.; Gigopulu, O.; Miova, B.; Suturkova, L.; Stefkov, G.
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies. Pharmaceuticals 2025, 18, 446.
https://doi.org/10.3390/ph18040446
AMA Style
Rafailovska E, Xhemaili E, Naumovska Z, Gigopulu O, Miova B, Suturkova L, Stefkov G.
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies. Pharmaceuticals. 2025; 18(4):446.
https://doi.org/10.3390/ph18040446
Chicago/Turabian Style
Rafailovska, Elena, Elona Xhemaili, Zorica Naumovska, Olga Gigopulu, Biljana Miova, Ljubica Suturkova, and Gjoshe Stefkov.
2025. "Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies" Pharmaceuticals 18, no. 4: 446.
https://doi.org/10.3390/ph18040446
APA Style
Rafailovska, E., Xhemaili, E., Naumovska, Z., Gigopulu, O., Miova, B., Suturkova, L., & Stefkov, G.
(2025). Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies. Pharmaceuticals, 18(4), 446.
https://doi.org/10.3390/ph18040446